BMS-345541 Hydrochloride: Selective IKK/NF-κB Pathway Inhibitor for Inflammation and Cancer Research

Executive Summary: BMS-345541 hydrochloride is a potent, selective inhibitor of the IκB kinase (IKK) complex, targeting IKK-1 (IC₅₀: 4 μM) and IKK-2 (IC₅₀: 0.3 μM) with high specificity (Zhao et al., 2025). It suppresses NF-κB-dependent transcription by preventing IκBα phosphorylation, thereby inhibiting pro-inflammatory cytokines such as TNFα, IL-1β, IL-6, and IL-8. BMS-345541 hydrochloride demonstrates full oral bioavailability and robust in vivo efficacy in mouse models. The compound induces apoptosis and G2/M phase arrest in T-cell acute lymphoblastic leukemia (T-ALL) cells, suggesting utility for chemotherapy resistance research. Its solubility profile (≥60 mg/mL in water) and minimal off-target kinase activity enable reliable experimental reproducibility (APExBIO).

Biological Rationale

The IKK/NF-κB signaling pathway is central to inflammatory and immune responses. Activation of NF-κB leads to transcription of genes that promote inflammation, cell survival, and proliferation. Dysregulation of this pathway underpins many chronic inflammatory diseases and cancers (Zhao et al., 2025). Selective inhibition of IKK subunits provides a strategy to dissect pathway function and modulate disease-relevant cytokine production. BMS-345541 hydrochloride allows for precise inhibition of IKK-1 and IKK-2 without affecting unrelated kinases, enabling focused research on NF-κB-driven transcription and downstream cellular responses. Compared to broad-spectrum kinase inhibitors, BMS-345541 hydrochloride minimizes confounding off-target effects and supports mechanistic studies in inflammation and cancer biology (See also: BMS-345541 Hydrochloride: Selective IKK Inhibition for NF...; this article extends the focus to in vivo and translational benchmarks).

Mechanism of Action of BMS-345541 hydrochloride

BMS-345541 hydrochloride is a small molecule that binds allosterically to the IKK complex, inhibiting the kinase activity of IKK-1 and IKK-2. The compound blocks the phosphorylation of IκBα, preventing its degradation. As a result, NF-κB remains sequestered in the cytoplasm and cannot translocate to the nucleus. This mechanism halts the transcription of NF-κB-dependent genes, including those encoding pro-inflammatory cytokines like TNFα, IL-1β, IL-6, and IL-8 (APExBIO). The selectivity for IKK-2 (IC₅₀: 0.3 μM) over IKK-1 (IC₅₀: 4 μM) is achieved without significant inhibition of other serine/threonine or tyrosine kinases, resulting in a clean pharmacological profile. This targeted action allows researchers to attribute observed cellular and molecular effects directly to NF-κB pathway inhibition.

Evidence & Benchmarks

• BMS-345541 hydrochloride inhibits IKK-2 activity with an IC₅₀ of 0.3 μM and IKK-1 with an IC₅₀ of 4 μM under standard in vitro kinase assay conditions (37°C, pH 7.4) (APExBIO).
• Selective for IKK subunits: does not affect other serine/threonine or tyrosine kinases at relevant concentrations (Zhao et al., 2025).
• Demonstrates 100% oral bioavailability in mouse pharmacokinetic studies, supporting effective in vivo delivery (APExBIO).
• Reduces TNFα production in mouse models of inflammation, confirming in vivo target engagement (Zhao et al., 2025).
• In vitro, BMS-345541 hydrochloride blocks stimulus-induced phosphorylation of IκB, halting NF-κB nuclear translocation (Related: Selective IKK Inhibitor for NF-...; this article clarifies application parameters and pharmacokinetic data).
• Induces apoptosis and G2/M phase arrest in T-ALL cell lines, suggesting potential utility in overcoming chemoresistance (See: Addressing NF-κB Pathway Challenges...; here, we expand on experimental protocols and solubility limits).

Applications, Limits & Misconceptions

BMS-345541 hydrochloride is widely used in research on inflammation, cytokine regulation, and cancer biology, particularly T-cell acute lymphoblastic leukemia (T-ALL). Its selectivity and reproducibility make it a preferred choice for dissecting the contribution of the IKK/NF-κB pathway in cellular and animal models. The compound is also valuable in studies of chemotherapeutic resistance due to its apoptosis-inducing properties in cancer cells. However, its utility is confined to experimental models and is not approved for clinical use in humans. Dose selection should be empirically determined for each assay, as efficacy and toxicity are cell-type and context-dependent. Storage and solubility parameters must be carefully observed to avoid loss of potency.

Common Pitfalls or Misconceptions

• Not a pan-kinase inhibitor: BMS-345541 hydrochloride does not inhibit unrelated kinases at standard concentrations; off-target effects are minimal (Zhao et al., 2025).
• Not suitable for clinical therapy: The compound is strictly for research use; no clinical trials support its use in patients (APExBIO).
• Solubility limitations: Insoluble in ethanol and DMSO at high concentrations; solutions should be prepared with warming and sonication (APExBIO).
• Requires storage at -20°C: Long-term storage of solutions degrades activity; fresh preparation is recommended for each experiment.
• Not universally effective in all cell lines: Sensitivity varies; optimization is necessary for each experimental context (Transforming IKK/NF-κB Pathway ...; this article details specific cell-type responses).

Workflow Integration & Parameters

BMS-345541 hydrochloride is supplied by APExBIO (SKU: A3248) as a high-purity (>98%) powder. For aqueous use, it is soluble at ≥60 mg/mL. Stock solutions can be prepared in DMSO with gentle warming and sonication. Working concentrations typically range from 0.04 to 100 μM, with precise dose titration recommended for each assay. Solutions should be prepared fresh or stored short-term at -20°C. For in vivo studies, the compound exhibits full oral bioavailability, facilitating oral gavage protocols in mouse models. Researchers should document buffer composition, temperature, and exposure time for all experiments to ensure reproducibility. For further guidance on troubleshooting apoptosis and viability assays, see Addressing NF-κB Pathway Challenges with BMS-345541 Hydro....

Conclusion & Outlook

BMS-345541 hydrochloride provides a robust, selective tool for inhibiting the IKK/NF-κB signaling pathway in inflammation and cancer biology research. Its well-characterized mechanism, high oral bioavailability, and minimal off-target effects underpin its reproducibility in both in vitro and in vivo settings. Researchers should adhere strictly to storage and solubility protocols to maximize experimental fidelity. As new models and disease contexts emerge, BMS-345541 hydrochloride will remain foundational in dissecting the molecular underpinnings of NF-κB-mediated pathology. For detailed product specifications and ordering, see the BMS-345541 hydrochloride product page.